ATE426016T1 - Pluripotent embryonale stammzellen-ahnliche zellen, zusammensetzungen und ihre vervendungen - Google Patents

Pluripotent embryonale stammzellen-ahnliche zellen, zusammensetzungen und ihre vervendungen

Info

Publication number
ATE426016T1
ATE426016T1 AT00965390T AT00965390T ATE426016T1 AT E426016 T1 ATE426016 T1 AT E426016T1 AT 00965390 T AT00965390 T AT 00965390T AT 00965390 T AT00965390 T AT 00965390T AT E426016 T1 ATE426016 T1 AT E426016T1
Authority
AT
Austria
Prior art keywords
stem cells
present
pluripotent
cells
stem cell
Prior art date
Application number
AT00965390T
Other languages
English (en)
Inventor
Henry Young
Paul Lucas
Original Assignee
Cybios Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cybios Llc filed Critical Cybios Llc
Application granted granted Critical
Publication of ATE426016T1 publication Critical patent/ATE426016T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00965390T 1999-09-24 2000-09-25 Pluripotent embryonale stammzellen-ahnliche zellen, zusammensetzungen und ihre vervendungen ATE426016T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40489599A 1999-09-24 1999-09-24
US66850800A 2000-09-22 2000-09-22

Publications (1)

Publication Number Publication Date
ATE426016T1 true ATE426016T1 (de) 2009-04-15

Family

ID=31720744

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965390T ATE426016T1 (de) 1999-09-24 2000-09-25 Pluripotent embryonale stammzellen-ahnliche zellen, zusammensetzungen und ihre vervendungen

Country Status (7)

Country Link
US (1) US20100239542A1 (de)
EP (2) EP2333049A1 (de)
JP (8) JP2004504003A (de)
AT (1) ATE426016T1 (de)
DE (1) DE60041821D1 (de)
DK (1) DK1218489T3 (de)
NZ (1) NZ518601A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009001509A (ja) * 2007-06-19 2009-01-08 Univ Nagoya 脂肪組織由来幹細胞を用いた組織再生用組成物
US9057051B2 (en) 2008-10-31 2015-06-16 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte progenitor phenotypes, cells produced by the methods, and methods of using the cells
AU2010276201B2 (en) * 2009-07-21 2013-10-17 Healios K.K. Use of stem cells to reduce leukocyte extravasation
ES2690199T3 (es) * 2009-07-21 2018-11-19 Abt Holding Company Uso de células madre para reducir la extravasación de leucocitos
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
SG10201913920PA (en) 2010-05-12 2020-03-30 Abt Holding Co Modulation of splenocytes in cell therapy
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9090878B2 (en) 2010-06-17 2015-07-28 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
SG188280A1 (en) 2010-08-24 2013-04-30 Univ Minnesota Non-static suspension culture of cell aggregates
WO2014123930A2 (en) * 2013-02-05 2014-08-14 Williams Joseph L Prevention and treatment of tissue fibrosis
IL289870B2 (en) 2013-04-12 2023-03-01 Lafrancesca Saverio Improving organs for transplantation
EP2999780B1 (de) 2013-05-22 2019-10-09 The Regents of the University of California Pluripotente menschliche adulte fettgewebestammzellen: isolierung, charakterisierung und klinische auswirkungen
CA2919374C (en) 2013-07-30 2019-12-03 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
KR20180102661A (ko) 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 상처 치유를 위한 줄기 세포
KR102303005B1 (ko) 2017-04-13 2021-09-16 닛폰세이테츠 가부시키가이샤 Sn 도금 강판 및 Sn 도금 강판의 제조 방법
GB2584664B (en) * 2019-06-10 2023-05-24 Newcells Biotech Ltd Improved retinal organoids and methods of making the same
US20230000071A1 (en) 2019-11-20 2023-01-05 Sumitomo Pharma Co., Ltd. Method for freezing neural cells
KR102179463B1 (ko) * 2019-12-06 2020-11-16 서울대학교 산학협력단 닭의 대흉근으로부터 확립된 근아섬유세포주 및 이를 이용한 생리활성물질 스크리닝 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4491632A (en) 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
EP0043718B1 (de) 1980-07-07 1984-11-28 National Research Development Corporation Zellinien
US4341761A (en) 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4466917A (en) 1981-02-12 1984-08-21 New York University Malaria vaccine
US4493890A (en) 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4451570A (en) 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4399121A (en) 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4493795A (en) 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
JPS63216476A (ja) * 1987-03-05 1988-09-08 Rikagaku Kenkyusho 無血清凍結保存用培地
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
JPH06217764A (ja) * 1993-01-22 1994-08-09 Snow Brand Milk Prod Co Ltd 細胞凍結保存用組成物
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
WO1998007841A1 (en) * 1996-08-19 1998-02-26 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplantation
JP2001501085A (ja) * 1996-09-23 2001-01-30 オントジニー インコーポレーテッド 造血幹細胞およびこのような細胞を生成するための方法
US5903934A (en) 1996-10-21 1999-05-18 Sears, Iii; Leonard W. Sanitary fixtures for use with a mobile patient lift
JPH10179165A (ja) * 1996-12-27 1998-07-07 Norin Suisansyo Chikusan Shikenjo 抗体磁気ビーズを用いた生殖幹細胞の分離、精製と幹細胞株の樹立方法
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
ATE307195T1 (de) * 1997-07-14 2005-11-15 Osiris Therapeutics Inc Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
WO1999027076A1 (en) * 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
ATE514772T1 (de) * 1999-08-05 2011-07-15 Abt Holding Co Multipotente erwachsene stammzellen und verfahren zu deren isolierung
AU7611500A (en) * 1999-09-24 2001-04-24 Abt Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof

Also Published As

Publication number Publication date
EP1903107A1 (de) 2008-03-26
JP6545335B2 (ja) 2019-07-17
DE60041821D1 (de) 2009-04-30
JP2019076094A (ja) 2019-05-23
JP2011167198A (ja) 2011-09-01
DK1218489T3 (da) 2009-06-02
JP2011103885A (ja) 2011-06-02
EP2333049A1 (de) 2011-06-15
JP2017079792A (ja) 2017-05-18
JP2014054258A (ja) 2014-03-27
JP2004504003A (ja) 2004-02-12
JP6539188B2 (ja) 2019-07-03
US20100239542A1 (en) 2010-09-23
NZ518601A (en) 2004-10-29
JP2016063818A (ja) 2016-04-28
JP2018174948A (ja) 2018-11-15

Similar Documents

Publication Publication Date Title
WO2001021767A3 (en) Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
ATE426016T1 (de) Pluripotent embryonale stammzellen-ahnliche zellen, zusammensetzungen und ihre vervendungen
EA200601187A1 (ru) Стволовые клетки
SE0201328L (sv) Hematopoietisk differentiering av humana embryonala stamceller
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
MY141772A (en) Isolation, cultivation and uses of stem/progenitor cells
WO2003023018A3 (en) A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
DK1201749T3 (da) Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter
IL210618A (en) Cell cultures containing isolated and multiplied human cells other than embryonic and germ cells, pharmaceutical preparations containing them, methods of preparation, and methods for identifying modulators and differentiation factors.
JP2010539970A5 (de)
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
WO2004015070A3 (en) Isolation and identification of t cells
CN106834218A (zh) 人羊膜上皮干细胞无血清培养基及其培养方法
BR0316757A (pt) Composições de meio de cultura de célula, processo para a cultura de célula progenitoras e/ou tronco, processo para a produção de mioblastos, população de células, e uso de mioblastos
ES2360434B1 (es) Celulas madre pluripotenciales obtenidas a partir de la pulpa dental.
WO2004009758A3 (en) Embryonic stem cell markers and uses thereof
CN103667184A (zh) 山羊骨骼肌卫星细胞体外培养方法
Deans et al. Stem cells in musculoskeletal engineered tissue
US8796020B2 (en) Manufacturing process for fresh and frozen stem cells
EP1954803B1 (de) Aus nabelschnurblut stammende multipotente stammzellen mit fähigkeit zur oct4-expression und verfahren zur präparation davon
EP1917348B1 (de) Isolierung von stammzellen mehrerer linien
WO2001083707A3 (en) Chondrocyte cultures and anti-angiogenic fractions therefrom
CN106834207A (zh) 一种中华鳖卵巢细胞分离及体外培养方法
CN113215098B (zh) 一种低成本原代小鼠脾脏网状成纤维细胞体外分离和培养方法
Scharler et al. Extra-hematopoietic immunomodulatory role of the SCID-susceptibility gene DOCK-2 identified by stepwise maturation of human iPSCs into clonogenic mesodermal stromal progenitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties